Arcus Biosciences Stock Forecast

Stock Price Forecast

The 10 analysts that cover Arcus Biosciences stock have a consensus rating of "Buy" and an average price target of $29.2, which forecasts a 34.94% increase in the stock price over the next year. The lowest target is $14 and the highest is $49.

Price Target: $29.2 (+34.94%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$14	$29.2	$28	$49
Change	-35.30%	+34.94%	+29.39%	+126.43%

Analyst Ratings

The average analyst rating for Arcus Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	3	3	3	4	4	4
Buy	3	3	3	2	1	2
Hold	2	2	2	3	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	9	9	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $44 → $45	Strong Buy	Maintains	$44 → $45	+107.95%	Mar 5, 2026
Geoffrey Porges Leerink Partners	Leerink Partners	Buy Maintains $36 → $49	Buy	Maintains	$36 → $49	+126.43%	Mar 2, 2026
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $32	Strong Buy	Reiterates	$32	+47.87%	Mar 2, 2026
Eva Fortea Verdejo Wells Fargo	Wells Fargo	Buy → Hold Downgrades $30 → $23	Buy → Hold	Downgrades	$30 → $23	+6.28%	Feb 12, 2026
Richard Law Goldman Sachs	Goldman Sachs	Hold → Strong Buy Upgrades $16 → $28	Hold → Strong Buy	Upgrades	$16 → $28	+29.39%	Jan 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

96.53M

from 247.00M

-60.92%

from 247.00M

Revenue Next Year

164.96M

from 96.53M

70.88%

from 96.53M

EPS This Year

-4.24

from -3.29

EPS Next Year

-3.41

from -4.24

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	383.00M	112.00M	117.00M	258.00M	247.00M	96.53M	164.96M
Revenue Growth	391.03%	-70.76%	4.46%	120.51%	-4.26%	-60.92%	70.88%
EPS	0.71	-3.71	-4.15	-3.14	-3.29	-4.24	-3.41
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	236.3M	372.2M
Avg	96.5M	165.0M
Low	6.9M	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-4.4%	285.5%
Avg	-60.9%	70.9%
Low	-97.2%	-

EPS Forecast

EPS	2026	2027
High	-3.33	-2.14
Avg	-4.24	-3.41
Low	-5.10	-3.79

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.